The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
Abstract
BACKGROUND: We tested the hypothesis that prophylactic cardiac-resynchronization therapy in the form of biventricular stimulation with a pacemaker with or without a defibrillator would reduce the risk of death and hospitalization among patients with advanced chronic heart failure and intraventricular conduction delays. METHODS: A total of 1520 patients who had advanced heart failure (New York Heart Association class III or IV) due to ischemic or nonischemic cardiomyopathies and a QRS interval of at least 120 msec were randomly assigned in a 1:2:2 ratio to receive optimal pharmacologic therapy (diuretics, angiotensin-converting-enzyme inhibitors, beta-blockers, and spironolactone) alone or in combination with cardiac-resynchronization therapy with either a pacemaker or a pacemaker-defibrillator. The primary composite end point was the time to death from or hospitalization for any cause. RESULTS: As compared with optimal pharmacologic therapy alone, cardiac-resynchronization therapy with a pacemaker decreased the risk of the primary end point (hazard ratio, 0.81; P=0.014), as did cardiac-resynchronization therapy with a pacemaker-defibrillator (hazard ratio, 0.80; P=0.01). The risk of the combined end point of death from or hospitalization for heart failure was reduced by 34 percent in the pacemaker group (P<0.002) and by 40 percent in the pacemaker-defibrillator group (P<0.001 for the comparison with the pharmacologic-therapy group). A pacemaker reduced the risk of the secondary end point of death from any cause by 24 percent (P=0.059), and a pacemaker-defibrillator reduced the risk by 36 percent (P=0.003). CONCLUSIONS: In patients with advanced heart failure and a prolonged QRS interval, cardiac-resynchronization therapy decreases the combined risk of death from any cause or first hospitalization and, when combined with an implantable defibrillator, significantly reduces mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While clinical improvements are generally achieved, six-month nonresponder rates have been reported to be as high as 32–43%11,13, which is partially attributed to anatomic constraints of lead positioning14.”
From Synchronized Biventricular Heart Pacing in a Closed-chest Porcine Model based on Wirelessly Powered Leadless Pacemakers (2020) · cites this paper as [13]
In the citing paper
“Device therapies (implantable cardioverter defibrillator [ICD], cardiac resynchronization therapy [CRT], and CRT with an implantable defibrillator [CRT-D]) have similar efficacies and risks in patients with HFrEF with or without diabetes.[522][523][524][525]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [524]
Citations
Cites
Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,902
Cardiac Resynchronization in Chronic Heart Failure
Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Packer, M., Clavell, A. L., Hayes, D. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013168 · Cited by 4,648
CARDIAC RESYNCHRONIZATION IN CHRONIC HEART FAILURE
Braham, W. I. T. A., Isher, W. E. G. F., Mith, L. S., Elurgio, D. A. B. D., Eon, A. N. R. L., Oh, E., Ocovic, D. U. Z. K., Acker, M. G., Lavell, L. C., Ayes, D. A. L. H., et al. (2002) · Cited by 3,808
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Self-citationDiscrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Self-citationSt John Sutton, M. G., Plappert, T., Abraham, W. T., Smith, A. L., DeLurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Fisher, W. G., Ellestad, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000065226.24159.e9 · Cited by 1,124
Auricchio, A., Stellbrink, C., Sack, S., Block, M., Vogt, J. Ü., Bakker, P., Huth, C., Schöndube, F., Wolfhard, U., Böcker, D., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01895-8 · Cited by 1,026
Linde, C., Leclercq, C., Rex, S., Garrigue, S., Lavergne, T., Cazeau, S., McKenna, W., Fitzgerald, M., Deharo, J.-C., Alonso, C., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01932-0 · Cited by 973
Baldasseroni, S., Opasich, C., Gorini, M., Lucci, D., Marchionni, N., Marini, M., Campana, C., Perini, G., Deorsola, A., Masotti, G., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.121264 · Cited by 800
Cited by
Items 901–1,000 of 1,014
Bonakdar, H. R., Jorat, M. V., Fazelifar, A., Alizadeh, A., Givtaj, N., Sameie, N., Sadeghpour, A., & Haghjoo, M. (2009) · EP Europace · doi:10.1093/europace/eup258 · Cited by 54
Kuschyk, J., Stach, K., Tülümen, E., Rudic, B., Liebe, V., Schimpf, R., Borggrefe, M., & Röger, S. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.06.022 · Cited by 54
Tigen, K., Karaahmet, T., Gürel, E., Çevik, C., NUGENT, K. M., Pala, S., Tanalp, A. C., Mutlu, B., & Başaran, Y. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70137-0 · Cited by 53
Kron, J., Aranda, J. M., Miles, W. M., Burkart, T. A., Woo, G. W., Saxonhouse, S. J., Sears, S. F., & CONTI, J. B. (2009) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-008-9330-2 · Cited by 55
Beetz, N., Rommel, C., Schnick, T., Neumann, E., Lother, A., Ordonez, E. B. M., Zeeb, M., Preißl, S., Gilsbach, R., Melchior‐Becker, A., et al. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.10.011 · Cited by 57
Hosseini, S. M., Moazzami, K., Rozen, G., Vaid, J., Saleh, A., Heist, E. K., Vangel, M. G., & Ruskin, J. N. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx100 · Cited by 55
Gasparini, M., Kloppe, A., Lunati, M., Anselme, F., Landolina, M., Martínez-Ferrer, J., Proclemer, A., Morani, G., Biffi, M., Ricci, R. P., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.1117 · Cited by 55
CSI position statement on management of heart failure in India
Guha, S., Harikrishnan, S., Ray, S., Sethi, R., Ramakrishnan, S., Banerjee, S., Bahl, V. K., Goswami, K. C., Banerjee, A. K., Shanmugasundaram, S., et al. (2018) · Indian Heart Journal · doi:10.1016/j.ihj.2018.05.003 · Cited by 65
Boriani, G., Regoli, F. D., Saporito, D., Martignani, C., Toselli, T., Biffi, M., Francolini, G., Diemberger, I., Reggiani, M. L. B., Rapezzi, C., et al. (2006) · Peptides · doi:10.1016/j.peptides.2006.02.010 · Cited by 53
Valzania, C., Biffi, M., Martignani, C., Diemberger, I., Bertini, M., Ziacchi, M., Reggiani, M. L. B., Rocchi, G., Rapezzi, C., Branzi, A., et al. (2007) · Echocardiography · doi:10.1111/j.1540-8175.2007.00491.x · Cited by 54
Cazeau, S., Daubert, J., Tavazzi, L., Fröhlig, G., & Paul, V. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.02.007 · Cited by 55
Verbeek, X. A. A. M., Auricchio, A., Yu, Y., Ding, J., Pochet, T., Vernooy, K., Kramer, A., Spinelli, J., & Prinzen, F. W. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00641.2005 · Cited by 54
The National ICD Registry: Now and into the future
Hammill, S. C., Phurrough, S. E., & Brindis, R. G. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.01.019 · Cited by 54
Bleeker, G. B., Schalij, M. J., Holman, E. R., Paul Steendijk, A., van der Wall, E. E., & Bax, J. J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.080 · Cited by 54
Stavrakis, S., Asad, Z. U. A., & REYNOLDS, D. W. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13204 · Cited by 54
Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024
ZHANG, S.-Y. (2025) · 老年心脏病学杂志:英文版 · doi:10.26599/1671-5411.2025.03.002 · Cited by 66
Fluoroscopically Guided Implantation of Modern Cardiac Resynchronization Devices
Perisinakis, K., Theocharopoulos, N., Damilakis, J. E., Manios, E. G., Vardas, P., & Gourtsoyiannis, N. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.070 · Cited by 54
Rickard, J., Bassiouny, M., Cronin, E. M., Martin, D. O., Varma, N., Niebauer, M. J., TCHOU, P. J., Tang, W. H. W., & Wilkoff, B. L. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.07.017 · Cited by 52
Peripartum cardiomyopathy: A review article
Karaye, K. M., & Henein, M. Y. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.11.069 · Cited by 55
“CRT also reduces all-cause mortality as well as rehospitalisation rate for HF, and to reverse remodelling particularly in non-ischemic heart diseases [56,57].”
BackgroundLeft Bundle Branch Block, an Old–New Entity
BREITHARDT, G. E., & Breithardt, O. A. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-011-9344-5 · Cited by 62
“trials have now shown its beneficial potential in patients with chronic heart failure [4, 5].”
BackgroundOttervanger, J. P., Misier, A. R. R., Dambrink, J. E., de Boer, M., Hoorntje, J. C. A., Gosselink, A. T. M., Suryapranata, H., Reiffers, S., & Hof, A. W. J. V. ’. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.101 · Cited by 53
Improvement of Congestive Heart Failure by Upgrading of Conventional to Resynchronization Pacemakers
Marai, I., Gurevitz, O. T., Carasso, S., Nof, E., Bar-Lev, D. S., Luria, D. M., Arbel, Y., Freimark, D., Feinberg, M. S., Eldar, M., et al. (2006) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2006.00455.x · Cited by 53
Foley, P. W. X., Patel, K., Irwin, N., Sanderson, J. E., Frenneaux, M. P., Smith, R. E. A., Stegemann, B., & Leyva, F. (2011) · Heart · doi:10.1136/hrt.2010.208355 · Cited by 52
Ginks, M., Duckett, S. G., Kapetanakis, S., Bostock, J., Hamid, S., Shetty, A., Ma, Y., Rhode, K., Carr‐White, G., Razavi, R., et al. (2011) · EP Europace · doi:10.1093/europace/eur336 · Cited by 52
Cardiovascular Disease in the Elderly
Jackson, C. F., & WENGER, N. K. (2011) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2011.05.003 · Cited by 78
Fischer, A., Ousdigian, K. T., Johnson, J. W., Gillberg, J. M., & Wilkoff, B. L. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.08.005 · Cited by 55
Morani, G., Gasparini, M., Zanon, F., Casali, E., Spotti, A., Reggiani, A., Bertaglia, E., Solimene, F., Molon, G., Accogli, M., et al. (2013) · EP Europace · doi:10.1093/europace/eut032 · Cited by 54
Sex and race differences in QRS duration
Hnatkova, K., Smetana, P., Toman, O., Schmidt, G. P., & Malík, M. (2016) · EP Europace · doi:10.1093/europace/euw065 · Cited by 54
Noda, T., Kurita, T., Nitta, T., Chiba, Y., Furushima, H., Matsumoto, N., Toyoshima, T., Shimizu, A., Mitamura, H., Okumura, K., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.11.077 · Cited by 53
Advanced ICD Troubleshooting: Part II
Swerdlow, C. D., & Friedman, P. A. (2006) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2006.00300.x · Cited by 54
Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design
TANG, A. S. L., Wells, G. A., Arnold, M., Connolly, S. J., Hohnloser, S. H., Nichol, G., Rouleau, J. L., Sheldon, R. S., & Talajic, M. R. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32831bc63b · Cited by 53
Rauwolf, T., Guenther, M., Hass, N., Schnabel, A., Bock, M., BRAUN, M. U., & Strasser, R. H. (2007) · EP Europace · doi:10.1093/europace/eum195 · Cited by 53
Hadwiger, M., Dagres, N., Haug, J., Wolf, M. S., Marschall, U., Tijssen, J. G. P., Katalinic, A., Frielitz, F., & Hindricks, G. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac053 · Cited by 54
“The COMPANION study compared CRT-P and CRT-D devices with optimal medical therapy, but there was no direct comparison between CRT-D and CRT-P.8 In the DANISH trial in patients with non-ischaemic cardiomyopathy, no benefit for CRT-D over CRT-P devices could be shown in the large trial subgroup that received a CRT devic…”
Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure
Sapp, J. L., Sivakumaran, S. T., Redpath, C. J., Khan, H. R., Parkash, R., Exner, D. V., Healey, J. S., Thibault, B., Sterns, L. D., Lam, N. H., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2304542 · Cited by 55
Foley, P. W. X., Stegemann, B., Ng, K., Ramachandran, S., Proudler, A. J., Frenneaux, M. P., Ng, L. L., & Leyva, F. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp300 · Cited by 52
Cowburn, P. J., Patel, H., Jolliffe, R. E., Wald, R. W., & Parker, J. D. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.11.005 · Cited by 51
Abraham, W. T., León, A. R., Sutton, M. G. S. J., Keteyian, S. J., Fieberg, A. M., Chinchoy, E., & Haas, G. J. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.07.026 · Cited by 51
Lenarczyk, R., Kowalski, O., Kukulski, T., Szulik, M., Pruszkowska‐Skrzep, P., Zielinska, T., Kowalczyk, J. P., Pluta, S., Duszańska, A., Średniawa, B., et al. (2007) · EP Europace · doi:10.1093/europace/eum140 · Cited by 53
Tatsumi, K., Tanaka, H., Tsuji, T., Kaneko, A., Ryo, K., Yamawaki, K., Omar, A. M., Fukuda, Y., Norisada, K., Matsumoto, K., et al. (2011) · Cardiovascular Ultrasound · doi:10.1186/1476-7120-9-11 · Cited by 53
“CRT is an established therapeutic option for HF patients with severe symptoms and a wide QRS complex [1-8].”
Bernal, O., & Moro, C. (2006) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(07)60011-5 · Cited by 51
Risum, N., Williams, E. S., Khouri, M. G., JACKSON, K. P., Olsen, N. T., Jøns, C., Storm, K. S., Velazquez, E. J., KISSLO, J. A., Bruun, N. E., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs035 · Cited by 52
Remodeling of Early-Phase Repolarization
Wang, Y., Cheng, J., Joyner, R. W., Wagner, M. B., & Hill, J. A. (2006) · Circulation · doi:10.1161/circulationaha.106.615682 · Cited by 52
Lindvall, C. J., Chatterjee, N. A., Chang, Y., Chernack, B., Jackson, V. A., Singh, J. P., & Metlay, J. P. (2015) · Circulation · doi:10.1161/circulationaha.115.018830 · Cited by 54
Osca, J., Alonso, P., Cano, Ó., Andrés, A., Miró, V., Tello, M. J. S., Olagüe, J., Martínez‐Dolz, L., & Salvador, A. (2015) · EP Europace · doi:10.1093/europace/euv211 · Cited by 52
Lee, J. H., Lee, S., Choi, E., Jeong, J.-H., Park, H., You, S.-J., Lee, S.-S., & Oh, S. (2019) · Korean Circulation Journal · doi:10.4070/kcj.2018.0444 · Cited by 54
Szilágyi, S., Merkely, B. P., Róka, A., Zima, E., Fülöp, G., Kutyifa, V., Szűcs, G., Becker, D. J., Apor, A., & Gellér, L. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00722.x · Cited by 52
Cardiac Resynchronization Therapy
Abraham, W. T. (2006) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2005.11.001 · Cited by 53
Optimizing sequential biventricular pacing using radionuclide ventriculography
Burri, H., Sunthorn, H., Somsen, G. A., Zaza, S., Fleury, E., Shah, D. C., & Righetti, A. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.05.017 · Cited by 51
Kára, T., Novák, M., Nykodym, J., Bybee, K. A., Meluzı́n, J., Orban, M., Nováková, Z., Lipoldová, J., Hayes, D. L., Soucek, M., et al. (2008) · CHEST Journal · doi:10.1378/chest.07-2832 · Cited by 52
Martin, D. T., McNitt, S., Nesto, R. W., Rutter, M. K., & Moss, A. J. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.959510 · Cited by 51
Skouri, H. N., Girerd, N., Monzo, L., Petrie, M. C., Böhm, M., Adamo, M., Müllens, W., Savarese, G., Yılmaz, M. B., Amir, O., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3618 · Cited by 59
Morken, I. M., Severinsson, E., & Karlsen, B. (2009) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2009.02898.x · Cited by 49
ADELSTEIN, E. C., Alam, M. B., SCHWARTZMAN, D. S., Jain, S. K., Marek, J. J., Gorcsan, J., & Saba, S. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.01.431 · Cited by 51
Thijssen, J., Borleffs, C. J. W., van Rees, J. B., de Bie, M. K., van der Velde, E. T., ERVEN, L. V., Bax, J. J., Cannegieter, S. C., & Schalij, M. J. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr161 · Cited by 51
Smiseth, O. A., Russell, K. E., & Skulstad, H. (2011) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ejechocard/jer243 · Cited by 51
Can optimization of pacing settings compensate for a non-optimal left ventricular pacing site?
Bogaard, M. D., Doevendans, P. A., Leenders, G. E. H., Loh, P. K. K., Hauer, R. N. W., van Wessel, H., & Meine, M. (2010) · EP Europace · doi:10.1093/europace/euq167 · Cited by 51
“In symptomatic patients with chronic congestive heart failure, a wide QRS complex and an impaired left ventricular (LV) ejection fraction, cardiac resynchronization therapy (CRT) improves morbidity and mortality of heart failure.(1,2) However, since a substantial percentage of these patients does not respond,(3) there…”
BackgroundNikolaidou, T., GHOSH, J. M., & Clark, A. L. (2016) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2016.02.012 · Cited by 56
Barra, S., Providencia, R. A., Narayanan, K., Bovéda, S., Duehmke, R. M., Garcia, R., Leyva, F., Roger, V. L., Jouven, X., Agarwal, S., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz773 · Cited by 51
Lyu, H., John, M., Burkland, D., Greet, B., Post, A., Babakhani, A., & Razavi, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-59017-z · Cited by 51
Ghali, J. K., Boehmer, J., Feldman, A. M., Saxon, L. A., Demarco, T., Carson, P., Yong, P., Galle, E. G., Leigh, J., Ecklund, F. L., et al. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.06.723 · Cited by 50
Self-citationElia, A., & Fossati, S. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1060666 · Cited by 58
“In this context, our Review analyzes current therapies to prevent and neutralize heart failure and their possible roles in reverting the cardiac neuronal maladaptive remodeling (Bristow et al., 2004).”
BackgroundCardiac Resynchronization Therapy: Do Women Benefit More Than Men?
XU, Y., Friedman, P. A., Webster, T. L., Brooke, K. L., Hodge, D. O., Wiste, H. J., Hua, W., Zhang, S., Hayes, D. L., & Cha, Y. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02168.x · Cited by 51
“Echocardiographic assessment included (1) LVEF; (2) left ventricular end-diastolic dimension (LVEDD); (3) mitral regurgitation (MR) severity (0 = none or trivial, 1 = mild, 2 = moderate, 3 = severe); and (4) pulmonary artery systolic pressure (PASP) estimated on the basis of the transtricuspid maximal regurgitant flow…”
MethodImprovements in 25 Years of Implantable Cardioverter Defibrillator Therapy
van Welsenes, G. H., Borleffs, C. J. W., van Rees, J. B., Atary, J. Z., Thijssen, J., van der Wall, E. E., & Schalij, M. J. (2010) · Netherlands Heart Journal · doi:10.1007/s12471-010-0047-3 · Cited by 54
“CRT-D reduced mortality by 36% in comparison with standard therapy, whereas CRT alone resulted in a 20% reduction in mortality [17].”
ResultDecreased Likelihood of Response to Cardiac Resynchronization in Patients with Severe Heart Failure
Vidal, B., Delgado, V., Mont, L., Poyatos, S., Silva, E., Castel, M., Tolosana, J. M., Berruezo, A., Brugada, J., & Sitges, M. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq003 · Cited by 56
Giardini, A., Fenton, M. J., Andrews, R., Derrick, G. P., & Burch, M. (2011) · Circulation · doi:10.1161/circulationaha.111.035956 · Cited by 54
Wessler, B. S., Kramer, D. G., Kelly, J. L., Trikalinos, T. A., Kent, D. M., Konstam, M. A., & Udelson, J. E. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.961573 · Cited by 51
Implantable cardioverter defibrillators and cardiac resynchronisation therapy
Holzmeister, J., & Leclercq, C. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61228-2 · Cited by 49
Gopinathannair, R., Birks, E. J., Trivedi, J. R., McCants, K., Sutton, B. S., Deam, A. G., Slaughter, M. S., & Hottigoudar, R. U. (2014) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.12.006 · Cited by 51
Atrial Support Pacing in Heart Failure: Results from the Multicenter PEGASUS CRT Trial
Martin, D. O., DAY, J. D., Lai, P. Y., Murphy, A. L., Nayak, H. M., Villareal, R. P., Weiner, S., Kraus, S. M., Stolen, K. Q., & Gold, M. R. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2012.02402.x · Cited by 50
Gopinathannair, R., Roukoz, H., Bhan, A., Ravichandran, A. K., Ahmed, M. M., Familtsev, D., Bhat, G., Cowger, J. A., Abdullah, M., Sandesara, C. M., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009091 · Cited by 48
McSwain, R. L., Schwartz, R. A., DeLurgio, D. B., Mera, F. V., Langberg, J. J., & León, A. R. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2005.40719.x · Cited by 50
Oyenuga, O. A., Hara, H., Tanaka, H., Kim, H.-N., ADELSTEIN, E. C., Saba, S., & Gorcsan, J. (2010) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2009.09.020 · Cited by 49
Narrative Review: Pharmacotherapy for Chronic Heart Failure: Evidence from Recent Clinical Trials
Yan, A. T.-K., Yan, R. T., & Liu, P. P. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-2-200501180-00013 · Cited by 52
Slotwiner, D. J., Raitt, M. H., Del-Carpio Munoz, F., Mulpuru, S. K., Nasser, N., & Peterson, P. N. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2018.10.035 · Cited by 49
Lip, G. Y. H., Heinzel, F. R., Gaïta, F., González‐Juanatey, J. R., Heuzey, J. Y. L., Potpara, T., Svendsen, J. H., Vos, M. A., Anker, S. D., Coats, A. J. S., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.338 · Cited by 53
Dual-Site Left Ventricular Cardiac Resynchronization Therapy
Padeletti, L., Colella, A., Michelucci, A., Pieragnoli, P., Ricciardi, G., Porciani, M. C., Tronconi, F., Hettrick, D. A., & Valsecchi, S. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.08.016 · Cited by 50
Clinical response of cardiac resynchronization therapy in the elderly
Delnoy, P. P. H. M., Ottervanger, J. P., Luttikhuis, H. O., Elvan, A., Misier, A. R. R., Beukema, W. P., & van Hemel, N. M. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.11.009 · Cited by 49
Crossley, G. H., Biffi, M., Johnson, B., LIN, A. C., Gras, D., Hussin, A., Cuffio, A., Collier, J., El‐Chami, M. F., Li, S., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.12.019 · Cited by 49
Gold, M. R., Yu, Y., Singh, J. P., Steín, K. M., Birgersdotter-Green, U. M., Meyer, T. E., Seth, M., & Ellenbogen, K. A. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.03.009 · Cited by 47
Ruwald, M. H., Ruwald, A., Jøns, C., Alexis, J. D., McNitt, S. A., Zaręba, W., & Moss, A. J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.020 · Cited by 53
Electrocardiographic patterns and long-term clinical outcome in cardiac resynchronization therapy
Kronborg, M. B., Nielsen, J. C., & Mortensen, P. T. (2009) · EP Europace · doi:10.1093/europace/eup364 · Cited by 49
Shimano, M., Tsuji, Y., Yoshida, Y., Inden, Y., Tsuboi, N., Itoh, T., Suzuki, H., Muramatsu, T., Okada, T., Harata, S., et al. (2007) · EP Europace · doi:10.1093/europace/eum119 · Cited by 51
Teng, A. E., Lustgarten, D. L., Vijayaraman, P., Tung, R. H., Shivkumar, K., Wagner, G. S., & Ajijola, O. A. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.05.049 · Cited by 50
(2008), G. D. T. D. L. E. P. E. D. Y. T. D. L. I. C. A. Y. C., & Desarrollada en colaboración con la Heart Failure Association (HFA) de la ESC y aprobada por la European Society of Intensive Care Medicine (ESICM) (2008) · Revista Española de Cardiología · doi:10.1016/s0300-8932(08)75740-3 · Cited by 83
Wang, C. C., Wu, C., Tsai, M., Lee, C., Huang, W. C., Chou, H., Huang, J. L., Chi, N., Yen, H., Tzeng, B., et al. (2019) · PubMed · doi:10.6515/acs.201905_35(3).20190422a · Cited by 54
Nuclear Imaging in Cardiac Resynchronization Therapy
Henneman, M. M., van der Wall, E. E., Ypenburg, C., Bleeker, G. B., de Veire, N. R. V., Marsan, N. A., Chen, J., Garcia, E. V., Westenberg, J. J. M., Schalij, M. J., et al. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.040360 · Cited by 49
“In addition, it has been demonstrated that CRT reduces hospitalization for heart failure and increases survival (8,9).”
BackgroundMethodKindermann, M., Adam, O., Werner, N., & Böhm, M. (2007) · Clinical Research in Cardiology · doi:10.1007/s00392-0591-z · Cited by 48
Cleland, J. G. F., Coletta, A. P., Freemantle, N., Velavan, P., Tin, L., & Clark, A. L. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.04.002 · Cited by 50
Narins, C. R., Aktaş, M. K., Chen, A. Y., McNitt, S. A., Ling, F. S., Younis, A., Zaręba, W., Daubert, J. P., Huang, D. T.-C., Rosero, S. Z., et al. (2021) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2021.06.020 · Cited by 53
Sohaib, S. M. A., Finegold, J. A., Nijjer, S. S., Hossain, R. R., Linde, C. M., Levy, W. C., Sutton, R., Kanagaratnam, P., Francis, D. P., & Whinnett, Z. I. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2014.11.007 · Cited by 51
Gorcsan, J., Søgaard, P., Bax, J. J., Singh, J. P., Abraham, W. T., BORER, J. S., Dickstein, K., Gras, D., Krum, H., Brugada, J., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv418 · Cited by 49
Defibrillation Energy Requirements in an ICD Population Receiving Cardiac Resynchronization Therapy
Schuger, C. D., Ellenbogen, K. A., Faddis, M. N., Knight, B. P., YONG, P., Sample, R., & for the VENTAK CHF/CONTAK CD Study Investigators (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00345.x · Cited by 48
Loring, Z., Caños, D., Selzman, K. A., Herz, N. D., SILVERMAN, H. J., MaCurdy, T. E., Worrall, C. M., Kelman, J. A., Ritchey, M. E., Piña, I. L., et al. (2013) · JACC Heart Failure · doi:10.1016/j.jchf.2013.03.005 · Cited by 48
Lellouche, N., Diego, C. D., Akopyan, G., Boyle, N. G., Mahajan, A., Cesario, D. A., Wiener, I., & Shivkumar, K. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.06.012 · Cited by 48
Rickard, J., Cheng, A., SPRAGG, D. D., Cantillon, D. J., Chung, M. K., Tang, W. H. W., Wilkoff, B. L., & Varma, N. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.09.018 · Cited by 55
Porciani, M. C., Dondina, C., Macioce, R., Demarchi, G., Cappelli, F., Lilli, A., Pappone, A., Ricciardi, G., Colombo, P. C., Padeletti, M., et al. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.08.001 · Cited by 48
Prognostic significance of QRS duration and morphology.
brenyo, A. J., & Zaręba, W. (2011) · PubMed · Cited by 47
Cardiac resynchronization therapy in heart failure patients with atrial fibrillation
Gasparini, M., Regoli, F., Galimberti, P., Ceriotti, C., & Cappelleri, A. (2009) · EP Europace · doi:10.1093/europace/eup273 · Cited by 46
“In fact, some studies have ‘indirectly’ suggested that the use of either digoxin oramiodarone in HF may increase morbidity and mortality.(4)”
ResultRoubíček, T., Wichterle, D., Kucera, P., Nedbal, P., Kupec, J., Sedlakova, J., Černý, J., Štros, J., Kautzner, J., & Polášek, R. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.003004 · Cited by 49
“24 MR (grade) 1 (1-2) 1 (1-2) 1 (1-2) 0.”
Merkely, B. P., Kosztin, A., Róka, A., Gellér, L., Zima, E., Kovács, A. D., Boros, A. M., Klein, H., Wranicz, J. K., Hindricks, G., et al. (2016) · EP Europace · doi:10.1093/europace/euw193 · Cited by 48
“(1) Age: over 18 years (2) Cardiomyopathy with LVEF ≤ 35%, ischaemic or non-ischaemic (3) Single- or dual-chamber PM or ICD implanted ≥6 months prior to enrolment (battery depletion or another indication for upgrade is not required) (4) RV pacing ≥20% in the prior ≥90 days (use of algorithms to avoid ventricular pacin…”
Method
Metadata
- Authors
- Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., DeVries, D. W., & Feldman, A. M.
- Affiliations
- University of Colorado Health (US)
- University of Southern California (US)
- Penn State Milton S. Hershey Medical Center (US)
- Bryan Health (US)
- Johns Hopkins Hospital (US)
- Veterans Health Administration (US)
- Pfizer (United States) (US)
- University of Wisconsin–Madison (US)
- Thomas Jefferson University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-05-20
- Volume
- 350
- Issue
- 21
- Pages
- 2140-2150
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2130907431
- Cited by
- 5,812
- References
- 22
- Citations by year
- 2026: 80 · 2025: 126 · 2024: 131 · 2023: 179 · 2022: 149 · 2021: 157 · 2020: 196 · 2019: 213 · 2018: 210 · 2017: 265 · 2016: 260 · 2015: 308 · 2014: 276 · 2013: 323 · 2012: 350
- FWCI
- 240.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
- Keywords
- cardiac resynchronization therapy, implantable cardioverter-defibrillator, advanced chronic heart failure, intraventricular conduction delay, heart failure hospitalization, mortality, cardiomyopathy, QRS duration, pharmacotherapy
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Angiotensin-Converting Enzyme Inhibitors, Chronic Disease, Combined Modality Therapy, Diuretics, Female, Heart Failure, Hospitalization, Humans, Male, Pacemaker, Artificial, Risk, Spironolactone, Defibrillators, Implantable, Ventricular Dysfunction, Left
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.